Evaluation of volumetric modulated arc therapy (VMAT) with Oncentra MasterPlan® for the treatment of head and neck cancer by Alvarez-Moret, Judith et al.
RESEARCH Open Access
Evaluation of volumetric modulated arc therapy
(VMAT) with Oncentra MasterPlan® for the
treatment of head and neck cancer
Judith Alvarez-Moret
*, Fabian Pohl, Oliver Koelbl, Barbara Dobler
Abstract
Background: Several comparison studies have shown the capability of VMAT to achieve similar or better plan
quality as IMRT, while reducing the treatment time. The experience of VMAT in a multi vendor environment is
limited. We compared the plan quality and performance of VMAT to IMRT and we investigate the effects of varying
various user-selectable parameters.
Methods: IMRT, single arc VMAT and dual arc VMAT were compared for four different head-and-neck tumors. For
VMAT, the effect of varying gantry angle spacing and treatment time on the plan quality was investigated. A
comparison of monitor units and treatment time was performed.
Results: IMRT and dual arc VMAT achieved a similar plan quality, while single arc could not provide an acceptable
plan quality. Increasing the number of control points does not improve the plan quality. Dual arc VMAT delivery
time is about 30% of IMRT delivery time.
Conclusions: Dual arc VMAT is a fast and accurate technique for the treatment of head and neck cancer. It applies
similar number of MUs as IMRT, but the treatment time is strongly reduced, maintaining similar or better dose
conformity to the PTV and OAR sparing.
Background
Intensity modulated radiotherapy (IMRT) is the standard
external radiotherapy technique to treat head-and-neck
tumors because of the clinical benefits of parotid glands
and spinal cord sparing [1-5]. Volumetric arc therapy
(VMAT) is an extension of IMRT, which allows irradiation
with simultaneously changing multileaf-collimator (MLC)
position, gantry position, and dose rate [6]. Various treat-
ment planning studies have been published showing the
potential of VMAT to reduce treatment time without
compromising plan quality compared to IMRT [7-14].
The result of VMAT optimization may, however,
depend on the choice of various plan parameters, e.g.
t h en u m b e ro fa r c s ,t h em a x i m a ld e l i v e r yt i m eo rt h e
gantry angle spacing between subsequent control points.
Some studies showed that single arc VMAT can achieve
dose distributions comparable to IMRT for prostate
cancer [15-17], but for more complicated planning tar-
get volume (PTV) as it is the case in the treatment of
head and neck cancer reports are contradictory. Most
publications state that two or more arcs are required
[15,18-20], whereas Bertelsen et al. [21] found that a
single arc is sufficient to achieve plan quality compar-
able to IMRT.
The purpose of this study was a treatment planning
comparison of IMRT and VMAT for head and neck car-
cinomas with different target geometries with Oncentra
Masterplan®. The focus was to investigate the influence
of various user-selectable parameters like number of
arcs, gantry angle spacing and the allowed maximal
delivery time on the plan quality and to identify the best
parameter set for optimal combination of plan quality
and treatment time.
Methods
Treatment planning system and equipment
A SynergyS® linear accelerator (Elekta Ltd, Crawley,
United Kingdom) with 6MV photons is used for IMRT
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of 4 mm width at isocenter. The following VMAT
specific parameters were determined: minimum and
maximum number of monitor units (MU) per degree of
gantry rotation (0.10 MU/° and 20.0 MU/°), minimum
MU per cm leaf travel (0.30 MU/cm), maximum
gantry speed (6.00 °/s), maximum leaf speed (2.4 cm/s),
static minimum leaf gap (0.0 cm), dynamic minimum
leaf gap (0.14 cm) and maximum nominal dose rate
(500 MU/min). For the SynergyS® a continuous variation
of the dose rate is not allowed. Seven fixed dose rate
values are available, each value is half the dose rate of
the next higher value. The linac selects automatically
the best combination of dose rate, gantry speed and leaf
speed. Therefore, the treatment time selected in the
optimization differs mostly from the delivery time.
Mosaiq® v1.6 (IMPAC Medical Systems, Sunnyvale, CA)
is used as record and verify system.
The treatment planning for IMRT and VMAT was
performed with Oncentra MasterPlan® v3.3 on a 64 bit
Window system with 8 GB RAM and 8-core processor.
This version supports VMAT planning for Elekta treat-
ment units with single arc, dual arc or multiple indivi-
dual arcs. Energy and collimator angle are defined by
the user in the Beam Modeling module. Both coplanar
and non-coplanar arcs are supported, with arbitrary col-
limator angles. The patient anatomy and targets are
defined; beams are defined specifying the isocenter,
beam energy, collimator angle, and couch angle for each
beam. For single arc VMAT, one beam per arc needs to
be defined. For dual arc VMAT an additional beam is
required and both beams must have the same beam
setup, while multiple single arc plans can have a differ-
ent beam setup.
The IMRT plans were optimized with the option
Direct Step and Shoot (DSS).T h i so p t i o nc o n s i s t so na
fluence optimization with subsequent leaf sequencing
for a few iterations (the sequencer creates a number of
segments equal or below the number predefined by the
user). The result of this first optimization is an initial
guess of the segments. Then, the leaf positions and
weights are optimized with a gradient algorithm. The
result is a set of MLC segments ready for delivery
[22-24]. For the VMAT plans the option VMAT was
used. Gantry start angle, arc length, gantry angle spacing
between control points and maximum delivery time are
defined by the user. The collimator angle is kept con-
stant for each arc. When using more than one arc, the
dual arc option can be used, this option groups the seg-
ments such, that the leaf movement is reduced; for
example, the first arc contains the segments positioned
to the right and the second arc to the left. After these
parameters have been defined, a few iterations are
performed to create coarse segments around the arc.
A fluence optimization is performed for these segments
and afterwards the fluence maps are converted in MLC
segments. Cloned segments are added until the final
gantry angle spacing is reached. At this point, the final
segments are optimized to fulfill the DVOs and machine
constraints. The continuous dose delivery is thus discre-
tized in control points (which can be defined changing
the gantry angle spacing) for dose calculation. This
implies that the dose is in fact approximated as being
delivered in discrete segments [25].
Oncentra MasterPlan® uses a fast pencil beam dose
calculation algorithm based on simplified value decom-
position during optimization and allows the user to
choose between pencil beam and collapsed cone for the
final dose calculation. In order to improve results it is
recommended to run the VMAT optimization twice. In
the cases I, II and III pencil beam was used for the
intermediate (i.e. first accurate) dose calculation. The
same algorithm was used for the final dose calculation
in these cases. For the case IV collapsed cone was used
for both calculations.
Both dose volume constraints (DVC) and dose volume
objectives (DVO) are available for DSS optimization,
while for the VMAT planning only DVOs are allowed.
A weight factor, which defines the priority of each
region of interest, must be assigned to each DVO. The
weights of the DVOs have an impact on the optimiza-
tion process; therefore the same DVOs and weights
were used for both VMAT and IMRT optimizations.
Treatment planning study
Patient anatomy, planning objectives and beam set-up
A selection of patients that underwent postoperative
irradiation with IMRT to treat head and neck malignan-
cies has been included in the study. Since the aim of the
study was to investigate the feasibility of VMAT with
the combination of Oncentra MasterPlan® and an Elekta
SynergyS® linear accelerator for head and neck cancer in
general, rather than a plan comparison with statistical
significance for only one type of cancer, four patients
with different typical target geometries were chosen:
I. Patient with a carcinoma of the oral cavity, PTV
800 ccm, TNM-classification: pT4pN0. PTV encom-
passes submental, submandibular, and subdigastric
nodes (Level I/II), the upper boarder includes the
hard palate with a 1-cm margin above (no “bite
block” to depress the tongue downwards was used
due to missing compliance), the inferior boarder was
at the level of the vocal chords. The dose prescrip-
tion was 60 Gy in 2Gy fractions to the PTV.
II. Patient with a carcinoma of the hypopharynx,
PTV 644 ccm, TNM-classification: pT2pN2a. The
PTV encompasses level I-VI nodal stations, the
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Page 2 of 10upper boarder is located in the nasopharynx, and the
inferior boarder includes the upper cervical esopha-
gus because of the propensity of these cancers to
spread submucosally. Dose prescription for the PTV
was 55.8 Gy to be delivered in 1.8 Gy fractions.
III. Patient with a carcinoma of the oral cavity, PTV
592 ccm, TNM-classification: pT4apN1. The PTV
encompasses submental, submandibular, and subdi-
gastric nodes (level I/II) and also level III -V nodal
stations because of nodal involvement, the upper
boarder includes the hard palate with a 1 cm margin
above (no “bite block” to depress the tongue down-
wards was used due to missing compliance), the
inferior boarder was the costoclavicular ligament
w i t has p l i t t i n go ft h et a r g e tv o l u m eo ft h ec e r v i c a l
nodes from the level of the vocal chords. Dose pre-
scription was 54 Gy in 1.8 Gy fractions to the PTV.
IV. Patient with a carcinoma of the nasal septum
(nasal cavity), 218 ccm, TNM-classification: pT2cN0.
The PTV encompasses the retroparyngeal lymph
nodes and the entire nasal cavity and ethmoid-sphe-
noid complex. The superior margin encompasses the
cribriform plate, the inferior border includes the
hard palate with a 1 cm margin. Dose prescription
was 54 Gy delivered in 1.8 Gy fractions to the PTV.
Figure 1 shows the patient anatomy for the four
selected cases.
For VMAT optimization it is not allowed to use
DVCs, so both techniques DSS-IMRT and VMAT were
optimized only with DVOs. For each patient, identical
D V O sw e r ea p p l i e dt ot h eo r g a n sa tr i s k( O A R )a n d
PTV for VMAT and IMRT. Although for patients II
a n dI I It h ed o s ep r e s c r i p t i o ni n c l u d e da na d d i t i o n a l
boost, to simplify the comparison, the study focuses
only on the dose prescription to the PTV without boost.
T h ep r i o r i t yw a st oa c h i e v ea tl e a s t9 5 %o ft h ep r e -
scribed dose to at least 95% of the PTV volume and to
keep the dose achieved to 5% of the PTV under 107% of
the prescribed dose. The tolerance dose values for each
OAR can be found in table 1. The DVOs were not iden-
tical to the tolerance dose values, because it was tried to
keep the dose achieved to the OARs as low as possible
below these values. The whole tissue without the PTV
was delineated and used as a help structure to avoid hot
spots.
For the patients I, II and III, the clinical step-and-
shoot IMRT plans were individually optimized using
seven coplanar fields (0°, 51°, 103°, 154°, 206°, 257° and
308°) and for the patient IV nine coplanar fields of 6
MV were used (0°, 40°, 80°, 120°, 160°, 200°, 240°, 280°,
320°). For the optimization of single arc VMAT gantry
angle spacing of 4° was selected and a maximal irradia-
tion time of 150 seconds was allowed (s4°150s) with an
arc ranging from 182° to 178°. The PTV was fully cov-
ered only for a collimator angle of 0° in all cases. For
patient IV, s4°150 s started at 150° and stopped at 330°
was performed with a collimator angle of 90 degrees
and a couch angle of 270°, for dual arc VMAT an addi-
tional arc from 250° to 100° with collimator angle 0°
and couch angle 0° was used. For the rest of the
patients, one arc ranging from 178° to 182° was added
f o rd u a la r c ,a l l o w i n gat i m eo f1 5 0sp e ra r c( d 4 ° 3 0 0 s ) .
For patient IV a non-coplanar 9-field IMRT plan
Figure 1 Patient anatomy. Patient anatomy contoured in Oncentra MasterPlan®.
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Page 3 of 10Table 1 Treatment plan comparison for patient I, II, III and IV
Patient I
IMRT s4°150s d4°300s d2°300s d6°300s d4°200s d4°400s Goal
D95% 58.2 56.6 57.9 57.7 57.4 58.0 57.6 57.0
PTV D5% 61.4 62.3 61.8 62.1 62.1 61.6 62.5 64.2
H 5.3 9.5 6.5 7.3 7.8 6.0 8.2 lower
CI (%) 0.98 0.94 0.98 0.97 0.96 0.98 0.98 1.0
Parotid le D50% 23.6 21.7 20.4 20.0 20.1 19.7 17.0 28
Parotid ri D50% 22.5 20.4 19.0 20.1 19.2 18.9 17.1 28
Brain stem D1ccm 43.2 44.5 44.1 42.6 42.9 44.4 44.3 50
Spinal cord D1ccm 46.4 50.9 44.1 43.7 45.0 44.1 44.0 48
MU 591.7 458.6 711.5 725.8 632.2 678.4 711.8 lower
treat. time (s) 686 116 200 222 225 235 207 lower
Patient II
D95% 54.2 53.2 53.9 53.7 54.0 52.9 53.9 53.5
PTV D5% 57.9 58.4 58.1 58.9 58.0 58.2 59.3 60.2
H 6.8 9.3 7.5 9.4 7.2 9.4 9.6 lower
CI (%) 0.97 0.94 0.97 0.95 0.97 0.92 0.97 1.0
Parotid le D50% 12.4 10.8 12.1 15.1 12.2 13.7 12.4 23
Parotid ri D50% 10.7 17.3 11.3 16.1 11.5 13.7 11.4 23
Brain stem D1ccm 33.6 30.9 29.7 31.9 30.8 37.9 30.1 41
Spinal cord D1ccm 35.7 37.5 35.8 33.8 35.5 36.0 35.6 40
MU 648.9 581.2 600.8 608.9 565.6 638.2 607.6 lower
treat. time (s) 729 120 225 264 227 279 248 lower
Patient III
D95% 51.5 51.2 51.6 50.5 51.3 52.0 51.4 51.3
PTV D5% 55.5 55.9 55.4 56.0 55.7 55.3 55.3 57.8
H 7.4 8.7 6.9 10.2 8.1 6.2 7.2 lower
CI (%) 0.96 0.95 0.96 0.92 0.95 0.97 0.95 1.0
Parotid le D50% 28.0 27.7 27.2 26.1 26.2 27.2 26.4 24
Parotid ri D50% 27.0 24.7 24.1 24.0 24.5 23.5 24.5 24
Brain stem D1ccm 36.5 35.6 31.9 38.2 31.9 31.5 31.6 43
Spinal cord D1ccm 40.7 40.8 39.3 42.0 39.1 38.6 39.2 41
MU 596.1 515.6 584.1 664.2 556.4 589.2 618.8 lower
treat. time (s) 753 115 225 303 213 240 246 lower
Patient IV
D95% 51.5 49.7 49.8 46.4 51.1 51.0 50.8 51.3
PTV D5% 55.4 56.5 55.9 59.8 58.0 55.6 56.1 57.8
H 7.2 12.6 11.3 24.8 12.8 8.5 9.8 lower
CI (%) 0.95 0.90 0.92 0.74 0.94 0.94 0.93 1.0
Spinal cord D1ccm 8.8 16.2 13.6 15.4 16.3 14.5 13.1 48
Brain stem D1ccm 43.0 51.4 36.6 34.5 38.4 36.8 37.3 50
Optic nerve le D1ccm 54.0 53.2 53.8 49.5 53.3 52.8 52.5 55
Optic nerve ri D1ccm 53.1 50.4 53.0 49.1 52.1 51.5 51.8 55
Chiasm D1ccm 29.5 30.2 27.2 27.5 25.5 24.9 25.5 50
Bulbus oculi le Dmed 17.0 17.3 14.9 14.2 14.0 14.3 13.7 20
Bulbus oculi ri Dmed 18.9 13.1 13.5 13.8 12.5 13.0 12.5 20
MU 464.9 409.8 462.5 598.4 445.0 477.7 450.9 lower
treat. time (s) 641 96 143 223 154 153 139 lower
Dmax is defined as dose to 1 ccm (D1ccm) of the structure volume. All dose values are given in Gy.
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Page 4 of 10(5 coplanar fields and 4 non-coplanar fields with couch
angle 270°) was compared with the 9-field coplanar
plan. Since there was no difference in PTV coverage
between both plans and in terms of OAR sparing the
plan with coplanar fields was similar or even slightly
better than the non-coplanar plan, the coplanar plan
was used for comparison.
To compare the impact of varying the time, following
set up was performed: d4°200 s (dual arc with 4° gantry
angle spacing, and 100 seconds per arc) and d4°400 s.
To investigate the effect on the plan quality of modify-
ing the gantry spacing, two additional plans were per-
formed for each case: d2°300 s and d6°300 s.
Plan evaluation
The evaluation of the plans was performed by means of
the dose-volume-histograms and the dose distribution.
For the PTV, D95%,D 5%, the homogeneity H, defined as
(D5% -D 95% )/Daverage , and the conformity index (CI)
(volume of the PTV receiving more than 95% of the
prescribed dose divided by the total volume of the PTV)
were evaluated. For the OARs spinal cord, brain stem,
optic nerve and chiasm, D1ccm (dose to 1 ccm of the
volume) was evaluated; for the parotid glands, Dmedian is
reported and for the bulbus oculi, Dmean was evaluated.
Dosimetrical verification
For dose measurement, the treatment plans were recal-
culated on a CT scan of the MatriXX Evolution® (IBA
Dosimetry, Schwarzenbruck, Germany) 2 D array,
between slabs of RW3. It consists of 1020 vented pixel
ionisation chambers in a square of 24.4 cm × 24.4 cm
with a distance of 7.6 mm between chambers. As back-
scatter material RW3 was used. An investigation about
the feasibility of hybrid plan verification has been pub-
lished previously [26]. The planning system does not
take the couch attenuation into consideration. To solve
this inconveniency, the MatriXX Evolution® has a gantry
angle sensor, which allows to correct for angular depen-
dencies including couch attenuation for each gantry
position. Plan verification was performed for the twelve
dVMAT plans with different gantry angle spacing of 2°,
4° and 6° (d2°300 s, d4°300 s, d6°300s). For patient IV it
was not possible to perform the verification of the origi-
nal plan because for the couch angle of 270°, the elec-
tronic system of the MatriXX would be irradiated.
Therefore the plan was recalculated setting the couch
angle to 0°. Evaluation of the verification was performed
using the gamma criterion with 3% dose tolerance and 3
mm distance to agreement. The gamma criterion was
considered fulfilled if g < 1 in at least 95% of the pixels.
Results
Step-and-shoot IMRT, single arc and dual arc VMAT
For this purpose, the IMRT plans were compared with
the single arc VMAT plan and the dual arc plan (with
gantry spacing 4° and maximal delivery time 300 s,
which are the default values of the treatment planning
system) in order to determine which technique can
achieve a better plan quality. Figure 2 shows the DVHs
for all patients and table 1 summarizes the results of
PTV coverage and OAR doses for all patients.
Single arc VMAT failed to achieve the required target
coverage and homogeneity in all cases, violating at the
same time the tolerance dose for at least one OAR in all
but one of the cases. Adding a second arc improved
plan quality considerably, leading to similar results as
IMRT. Target goal doses were achieved and OAR toler-
ance doses respected in all cases.
Maximal delivery time
A comparison of d4°200 s, d4°300 s and d4°400 s was
performed. Figure 3 shows the DVH for all patients.
Table 1 shows the results of PTV coverage and OAR
doses for all patients. No systematic influence of the
delivery time on the plan quality was observed for the
p a t i e n tIa n dI I I .F o rp a t i e n tI I ,r e d u c i n gt h et i m e
from 300 s to 200 s deteriorated the target coverage
and OAR sparing, but the values were still below tol-
erance. For the last case, patient IV, the plan with
300 s showed a slightly inferior quality than the plans
with 200 s and 400 s, but they were within the
tolerances.
Gantry angle spacing
The best plan quality was achieved with 4° and 6° gantry
spacing, reducing the gantry spacing to 2° led to a dete-
riorated plan quality in some of the cases. Figure 4
shows the DVH comparison of the plans d2°300 s, d4°
300 s and d6°300 s for all patients. Table 1 shows the
results of PTV coverage and OAR doses for all patients.
For patient I and II the modification of the number of
control points achieved no plan quality improvement.
Figure 4 shows that the DVHs were similar, but for the
patient II, the dose to the OARs was slightly higher
when applying 2°. For patient III, the plans with 4° and
6° achieved similar plan quality. When the gantry spa-
cing was decreased to 2°, the DVH shows inferior target
coverage and OARs dose sparing. The same effect was
observed for patient IV; no acceptable target coverage
could be achieved by using 2° gantry spacing, while the
plans with 4° and 6° achieved a comparable dose
distribution.
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The lowest number of MU per fraction dose was
required for the single arc technique.
Dual arc resulted in similar or higher MU as IMRT,
depending on the gantry spacing: The larger the gantry
spacing, the lower the number of MU. Detailed informa-
tion for each patient is given in table 1.
Regarding the treatment time it was observed that
varying the gantry spacing does not affect the treatment
time. The mean time for the plans d4°300 s was 198 s
and 205 s for those with 6°. For the plans with 2°, the
mean treatment time was 253 s. No significant differ-
ence was found between allowing the system 200, 300
or 400 seconds (from 300 s to 400 s), the irradiation
time takes in average 227 s when allowing a maximal
time of 200 s and 210 s when allowing a maximal time
of 400 s. IMRT irradiation time was in average 702 s.
Table 1 summarizes the irradiation time for each plan.
Dual arc VMAT irradiation time is about one-third of
IMRT time.
Dosimetrical verification
The results listed in table 2 show that the dosimetric
verification of the plans with different gantry angle spa-
cing showed good agreement of measured und calcu-
lated doses, passing the gamma test in all but one of the
cases (patient III, with 4° and 6°). Averaged over all
plans, the gamma evaluation was fulfilled in 97.2% of
the pixels for the plans optimized with 2° gantry angle
spacing, in 97.0% for the plans with 4° and 96.5% for the
plans with 6°. Figure 5 shows the gamma evaluation for
all patients.
Discussion
In our planning study we demonstrated that VMAT
performed with a SynergyS® linear accelerator is an
appropriate technique to treat head and neck cancer.
Recent planning studies have shown that VMAT could
achieve conformal dose distributions for prostate and
lung [10,11,27], which have a regular shape. For more
complicated tumor sites as head and neck tumors, some
Figure 2 Technique comparison study. DVH comparison of IMRT, single arc VMAT and dual arc VMAT for all patients.
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Page 6 of 10studies revealed the requirement of an additional arc,
because single arc does not succeed in achieving a plan
quality comparable to IMRT [15,18,19]. On the other
hand, other studies suggest that a single arc is good
enough [6,21]. The results of the current investigation
coincide with the mentioned VMAT studies for head
and neck studies, which affirm that two arcs are
required. In the present investigation it was first tried to
fulfill the objectives planning with single arc, but no suf-
ficient plan quality could be reached. Therefore, the
study of the influence of the beam-on time and gantry
angle spacing was performed with dual arc VMAT. It
has been shown, that with the combination of Oncentra
MasterPlan® and Elekta linear accelerator, dual arc
VMAT is required to achieve an acceptable plan quality.
The investigation of how the parameter maximal beam
on time affects the plan quality showed that there is no
identifiable difference in plan quality when increasing
the treatment time. The plan quality became not better
and the planning time increases. Furthermore, the addi-
tional time allowed for the plan d4°400 s was actually
not used by the optimizer. Therefore, to use the default
value of 150 seconds or even reducing it to 100 seconds
per arc should be sufficient. Another factor which may
affect the quality is the gantry angle spacing, which
defines how many control points (or discrete segments)
will be used for optimization and dose calculation. The
continuous VMAT irradiation is approximated by dis-
crete segments, the closer they are the better is the
approximation to a continuous arc irradiation. There-
fore, the agreement of measured and calculated dose is
expected to increase when reducing the gantry angle
spacing. Feygelman et al. [28] have confirmed this beha-
vior when calculating the dose with a large spacing of 6°
between control points. They found a dependence of the
plan complexity on the sensitivity to the gantry angle
spacing. Our investigation could not confirm this beha-
vior. The results of our study reveal that the plan quality
remains practically not affected when modifying this
parameter (figure 4). For two patients, the plans with 2°
achieved a lower plan quality. Particularly for the patient
IV this effect was considerable. The reason can be the
tip of the nose, because the algorithm has complications
to calculate the dose. For 2° gantry angle spacing there
Figure 3 Irradiation time comparison study. DVH comparison of d4°200 s, d4°300 s and d4°400 s for patient all patients.
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Page 7 of 10are more segments in this region as for the plans with 4°
and 6°, so there are more segments that can be affected
by this effect. The dose validation shows that there is no
dependence on the gantry spacing for the agreement of
the dose calculation and the measured dose (table 2).
Furthermore, reducing the gantry angle to 2° increases
the calculation time by a factor of 1.6. For this reason,
we conclude that planning with a gantry spacing of 4°
or even 6° is reasonable. Some studies [15,18,19] have
shown that VMAT reduces considerably the number of
MU compared with IMRT. In our planning experience,
the number of MUs of dual arc VMAT is similar as
those of the IMRT. However, the MU of the step-and-
shoot IMRT plans for the Elekta linear accelerator are
lower than those presented in the mentioned studies for
sliding window technique with a Varian machine
[18,19].
We have presented four patient cases in which VMAT
could have advantage to the patient compared with
IMRT, dual arc VMAT with 4° gantry angle spacing and
300 seconds is a good compromise between plan quality,
dose verification agreement and treatment time. Espe-
cially regarding the treatment time, table 1 shows that
delivery time of IMRT takes about 12 minutes, for
VMAT the time can be reduced by a factor of about 0.3
for dual arc and 0.15 for single arc. The quality assur-
ance process is identical for IMRT and VMAT, but the
IMRT plan delivery to the phantom takes longer than
the VMAT delivery.
The treatment planning with the VMAT option
becomes more complicated than for IMRT because of
the high number of parameters which can be modified.
The default values of VMAT planning for maximal
Figure 4 Gantry angle spacing comparison study. DVH comparison of d2°300 s, d4°300 s and d6°300 s for patient all patients.
Table 2 Gamma evaluation
d2°300s d4°300s d6°300s
I 96.60 95.35 98.06
II 96.56 97.95 97.09
III 95.83 94.92 92.80
IV 99.85 99.87 98.02
Gamma evaluation of the gantry spacing study with 3%, 3 mm criterion.
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Page 8 of 10treatment time per arc is 150 seconds and for the gantry
angle spacing 4°. With this configuration, the treatment
planning time increases by a factor of 7 when using sin-
gle arc VMAT and a factor of about 14 for dual arc
compared to IMRT.
It could be shown that dual arc with 4° gantry angle
spacing and 150 seconds per arc is the best parameter
set to achieve optimal combination of plan quality and
treatment delivery time for head and neck cancer. How-
ever, these results are vendor-specific and similar com-
parison studies for other treatment planning systems
and linear accelerators should be performed to general-
ize these results.
Conclusions
Dual arc VMAT with Oncentra MasterPlan® can achieve
a comparable or superior plan quality to IMRT for all
types of head and neck cancer included in this study.
Both single arc and dual arc VMAT reduce the treat-
ment time drastically compared with IMRT, but the
plan quality of single arc was not sufficient. However,
the cost of the improvement of the delivery time is that
the calculation time increases. Allowing more treatment
time does not actually improve the quality and increases
the treatment planning time. The dosimetric validation
has shown, that even performing the optimization with
a large gantry angle spacing of 6° the results are as good
Figure 5 Gamma evaluation. Gamma evaluation of the gantry angle spacing comparison.
Alvarez-Moret et al. Radiation Oncology 2010, 5:110
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Page 9 of 10as with 2° and 4°. Optimizing with larger gantry spacing
could help to reduce the calculation time without com-
promising the plan quality.
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